Dynamic Technology Lab’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Dynamic Technology Lab’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,899	Closed	-$263K	–	1493
2020 Q2	$263K	Buy	+7,899	New	+$252K	0.04%	722
2017 Q2	–	Sell	-11,795	Closed	-$158K	–	1440
2017 Q1	$158K	Buy	+11,795	New	+$185K	0.04%	846
2016 Q3	–	Sell	-10,096	Closed	-$109K	–	1262
2016 Q2	$109K	Buy	+10,096	New	+$104K	0.03%	793
2016 Q1	–	Sell	-13,200	Closed	-$196K	–	1277
2015 Q4	$196K	Buy	+13,200	New	+$221K	0.06%	716
2014 Q3	–	Sell	-12,341	Closed	-$149K	–	932
2014 Q2	$149K	Buy	+12,341	New	+$146K	0.07%	557
2013 Q4	–	Sell	-16,474	Closed	-$237K	–	733
2013 Q3	$237K	Buy	+16,474	New	+$252K	0.19%	255

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Dynamic Technology Lab's MNTA Position: Q3 2020 in Review

Dynamic Technology Lab sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 7,899 shares — an estimated $263K sold.

Dynamic Technology Lab first reported a position in MNTA in Q3 2013 and held it in 6 quarters. The position peaked at $263K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Dynamic Technology Lab reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Dynamic Technology Lab sold 7,899 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $263K.
Dynamic Technology Lab first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
Dynamic Technology Lab's Momenta Pharmaceuticals, Inc. position peaked at $263K in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Dynamic Technology Lab's 13F filing for Q3 2020, filed 13 Nov 2020.